FDA approves fifth RNAi drug — Alnylam’s next-gen hATTR treatmentAsher Mullard라이브러리에 저장컬렉션에 추가2022Nature Reviews Drug Discovery34 citationsDOITopics & ConceptsPharmacologyDrugApproved drugMedicineCancer Genomics and DiagnosticsPI3K/AKT/mTOR signaling in cancerProtein Degradation and Inhibitors